N. Danis Et Al. , "Paritaprevir, ritonavir, ombitasvir, and dasabuvir treatment in renal transplant patients with hepatitis C virus infection," TURKISH JOURNAL OF GASTROENTEROLOGY , vol.30, no.8, pp.695-701, 2019
Danis, N. Et Al. 2019. Paritaprevir, ritonavir, ombitasvir, and dasabuvir treatment in renal transplant patients with hepatitis C virus infection. TURKISH JOURNAL OF GASTROENTEROLOGY , vol.30, no.8 , 695-701.
Danis, N., TÖZ, H., ÜNAL, N. G., YILMAZ, M., TURAN, İ., Gunsar, F., ... KARASU, A. Z.(2019). Paritaprevir, ritonavir, ombitasvir, and dasabuvir treatment in renal transplant patients with hepatitis C virus infection. TURKISH JOURNAL OF GASTROENTEROLOGY , vol.30, no.8, 695-701.
Danis, NİLAY Et Al. "Paritaprevir, ritonavir, ombitasvir, and dasabuvir treatment in renal transplant patients with hepatitis C virus infection," TURKISH JOURNAL OF GASTROENTEROLOGY , vol.30, no.8, 695-701, 2019
Danis, NİLAY Et Al. "Paritaprevir, ritonavir, ombitasvir, and dasabuvir treatment in renal transplant patients with hepatitis C virus infection." TURKISH JOURNAL OF GASTROENTEROLOGY , vol.30, no.8, pp.695-701, 2019
Danis, N. Et Al. (2019) . "Paritaprevir, ritonavir, ombitasvir, and dasabuvir treatment in renal transplant patients with hepatitis C virus infection." TURKISH JOURNAL OF GASTROENTEROLOGY , vol.30, no.8, pp.695-701.
@article{article, author={NİLAY DANIŞ Et Al. }, title={Paritaprevir, ritonavir, ombitasvir, and dasabuvir treatment in renal transplant patients with hepatitis C virus infection}, journal={TURKISH JOURNAL OF GASTROENTEROLOGY}, year=2019, pages={695-701} }